Patent details

EP3868768 Title: PHARMACEUTICAL CRYSTAL OF CONTEZOLID ACEFOSAMIL, PREPARATION METHOD THEREFOR, AND USES THEREOF

Basic Information

Publication number:
EP3868768
PCT Application Number:
CN2019109063
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP198726515
PCT Publication Number:
WO2020078205
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL CRYSTAL OF CONTEZOLID ACEFOSAMIL, PREPARATION METHOD THEREFOR, AND USES THEREOF
French Title of Invention:
PRODUIT PHARMACEUTIQUE CRISTALLIN DE CONTEZOLID ACÉFOSAMIL, SON PROCÉDÉ DE PRÉPARATION ET SES APPLICATIONS
German Title of Invention:
PHARMAZEUTISCHER KRISTALL VON CONTEZOLID ACEFOSAMIL, HERSTELLUNGSVERFAHREN DAFÜR UND VERWENDUNGEN DAVON
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
25/06/2024
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
04/07/2024
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
12/06/2024
Unitary Effect Registration Date:
04/07/2024
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
29/09/2019
Grant date:
12/06/2024
EP Publication Date:
25/08/2021
PCT Publication Date:
23/04/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/06/2024
EP B1 Publication Date:
12/06/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/09/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/06/2024
 
 

Name:
Shanghai MICURX Pharmaceutical Co., Ltd.
Address:
3/F, Blgd. B, No. 1976 Middle Gaoke Road Pudong New District, Shanghai 201203, China (CN)

Inventor

1

Name:
WANG, Xinghai
Address:
China (CN)

2

Name:
LIU, Jinqian
Address:
China (CN)

3

Name:
GORDEEV, Mikhail Fedorovich
Address:
United States (US)

4

Name:
ZHANG, Xueliang
Address:
China (CN)

Priority

Priority Number:
201811197435
Priority Date:
15/10/2018
Priority Country:
China (CN)

Classification

IPC classification:
C07F 9/6558; A61P 31/00; A61P 31/04; A61K 31/675;

Publication

European Patent Bulletin

1

Issue number:
202424
Publication date:
12/06/2024
Description:
Grant (B1)

2

Issue number:
202431
Publication date:
31/07/2024
Description:
Unitary Effect Request Receipt

3

Issue number:
202432
Publication date:
07/08/2024
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages